Open Access Articles- Top Results for SB-357134


Systematic (IUPAC) name
Clinical data
PubChem CID 6918553
ChemSpider 5293750 7pxN
ChEMBL CHEMBL329383 7pxN
Chemical data
Formula C17H18Br2FN3O3S
523.214 g/mol
 14pxN (what is this?)  (verify)

SB-357134 is a drug which is used in scientific research. It acts as a potent, selective and orally active 5-HT6 receptor antagonist.[1] SB-357134 and other 5-HT6 antagonists show nootropic effects in animal studies,[2][3][4] and have been proposed as potential novel treatments for cognitive disorders such as schizophrenia and Alzheimer's disease.


  1. ^ Bromidge, SM; Clarke, SE; Gager, T; Griffith, K; Jeffrey, P; Jennings, AJ; Joiner, GF; King, FD et al. (2001). "Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)". Bioorganic & Medicinal Chemistry Letters 11 (1): 55–8. PMID 11140733. doi:10.1016/S0960-894X(00)00597-7. 
  2. ^ Rogers, DC; Hagan, JJ (2001). "5-HT6 receptor antagonists enhance retention of a water maze task in the rat". Psychopharmacology 158 (2): 114–9. PMID 11702084. doi:10.1007/s002130100840. 
  3. ^ Stean, TO; Hirst, WD; Thomas, DR; Price, GW; Rogers, D; Riley, G; Bromidge, SM; Serafinowska, HT et al. (2002). "Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist". Pharmacology, Biochemistry, and Behavior 71 (4): 645–54. PMID 11888556. doi:10.1016/S0091-3057(01)00742-0. 
  4. ^ Perez-García, G; Meneses, A (2005). "Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task". Pharmacology, Biochemistry, and Behavior 81 (3): 673–82. PMID 15964617. doi:10.1016/j.pbb.2005.05.005. 

Lua error in package.lua at line 80: module 'Module:Buffer' not found.